BioSpace News Archive

Select Medical Holdings Corporation today announced the appointment of Marilyn Tavenner to its Board of Directors (the “Board”), effective on November 1, 2018. Her Board term will expire at Select Medical’s 2019 Annual Meeting of Stockholders, at which time she will stand for election along with the other director nominees standing for election at that meeting.

In conjunction with DURECT Corporation’s (Nasdaq: DRRX) third quarter 2018 financial results press release, you are invited to listen to a conference call that will be broadcast live over the internet on Wednesday, November 7, 2018 at 4:30 pm Eastern Time (1:30 pm Pacific Time).

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2018.

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2018

Presentations to feature key opinion leaders and expand on preclinical data from Synlogic’s first immuno-oncology candidate, accepted for presentation at SITC 2018

Lantheus Holdings Inc today announced that Company management will participate in analyst-led fireside chat discussions at the following conferences.

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the third quarter of 2018 and provided an update on progress toward fulfilling its key corporate objectives, as well as commercial and clinical development milestones.

-Positive Phase 3 ECHELON-2 Clinical Trial Results to be Presented in Oral Session on Monday, December 3rd-

Bovie Medical Corporation (NYSEAMERICAN:BVX) (the “Company”), a maker of medical devices and supplies and the developer of J-Plasma®, a patented surgical product marketed and sold under the Renuvion® Cosmetic Technology brand in the cosmetic surgery market, today reported financial results for its third quarter ended September 30, 2018.

Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, today reported financial results for the third quarter ended September 30, 2018. “